{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T19:38:22Z","timestamp":1775331502705,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.seizure.2009.10.008","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T21:42:04Z","timestamp":1259358124000},"page":"31-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review"],"prefix":"10.1016","volume":"19","author":[{"given":"Hui Jeen","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Martland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Appleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Kneen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2009.10.008_bib1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.eplepsyres.2005.11.004","article-title":"Introduction to zonisamide","volume":"68","author":"Baulac","year":"2006","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0920-1211(89)90041-7","article-title":"Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant","volume":"3","author":"Rock","year":"1989","journal-title":"Epilepsy Research"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1059-1311(96)80104-X","article-title":"Mechanisms of T-type calcium channel blockade by zonisamide","volume":"5","author":"Kito","year":"1996","journal-title":"Seizure"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2009.10.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures","volume":"116","author":"Ueda","year":"2003","journal-title":"Brain Research. Molecular Brain Research"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/j.1552-4604.1998.tb04406.x","article-title":"Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures","volume":"38","author":"Kochak","year":"1998","journal-title":"Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1016\/j.seizure.2009.10.008_bib6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0091270004268045","article-title":"Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy","volume":"44","author":"Levy","year":"2004","journal-title":"Journal of Clinical Pharmacology"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.ftd.0000153403.99478.1f","article-title":"Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy","volume":"27","author":"Levy","year":"2005","journal-title":"Therapeutic Drug Monitoring"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.06.008","article-title":"Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients","volume":"62","author":"Ragueneau-Majlessi","year":"2004","journal-title":"Epilepsy Research"},{"issue":"5","key":"10.1016\/j.seizure.2009.10.008_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003088-200544050-00005","article-title":"Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy","volume":"44","author":"Ragueneau-Majlessi","year":"2005","journal-title":"Clinical Pharmacokinetics"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/088307380201700201","article-title":"Zonisamide in pediatric epilepsy: review of the Japanese experience","volume":"17","author":"Glauser","year":"2002","journal-title":"Journal of Child Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.seizure.2009.10.008_bib11","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.eplepsyres.2005.11.007","article-title":"Zonisamide in the management of epilepsy\u2014Japanese experience","volume":"68","author":"Ohtahara","year":"2006","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Research"},{"issue":"10","key":"10.1016\/j.seizure.2009.10.008_bib13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/WNL.57.10.1774","article-title":"Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures","volume":"57","author":"Faught","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.seizure.2009.10.008_bib14","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0013-9580.2004.11403.x","article-title":"Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures","volume":"45","author":"Sackellares","year":"2004","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.0013-9580.2005.14704.x","article-title":"Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2005.02.003","article-title":"Use of zonisamide in pediatric patients","volume":"33","author":"Santos","year":"2005","journal-title":"Pediatric Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2009.10.008_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/08830738050200030801","article-title":"Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center","volume":"20","author":"Kim","year":"2005","journal-title":"Journal of Child Neurology"},{"issue":"7","key":"10.1016\/j.seizure.2009.10.008_bib18","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/08830738050200071101","article-title":"Broad-spectrum efficacy of zonisamide at 12 months in children with intractable epilepsy","volume":"20","author":"Mandelbaum","year":"2005","journal-title":"Journal of Child Neurology"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpn.2007.05.003","article-title":"Long-term use of zonisamide in refractory childhood-onset epilepsy","volume":"12","author":"Kluger","year":"2008","journal-title":"European Journal of Paediatric Neurology"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2009.10.008_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eplepsyres.2008.10.012","article-title":"Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study","volume":"83","author":"Coppola","year":"2009","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpn.2008.01.004","article-title":"Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy","volume":"13","author":"Shinnar","year":"2009","journal-title":"European Journal of Paediatric Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2009.10.008_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.0013-9580.2004.06304.x","article-title":"Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society","volume":"45","author":"French","year":"2004","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.seizure.2009.10.008_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pediatrneurol.2005.10.007","article-title":"Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy","volume":"34","author":"Kothare","year":"2006","journal-title":"Pediatric Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2004.08.006","article-title":"Zonisamide monotherapy for epilepsy in children and young adults","volume":"32","author":"Wilfong","year":"2005","journal-title":"Pediatric Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2009.10.008_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/01.WNL.0000103284.73495.35","article-title":"Zonisamide treatment for symptomatic infantile spasms","volume":"62","author":"Lotze","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.seizure.2009.10.008_bib26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1684\/j.1950-6945.2004.tb00075.x","article-title":"Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy","volume":"6","author":"Kothare","year":"2004","journal-title":"Epileptic Disorders"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2009.10.008_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2005.02.006","article-title":"Zonisamide for absence seizures","volume":"64","author":"Wilfong","year":"2005","journal-title":"Epilepsy Research"},{"issue":"4","key":"10.1016\/j.seizure.2009.10.008_bib28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.braindev.2007.09.004","article-title":"Clinical efficacy of zonisamide in Lennox\u2013Gastaut syndrome: Korean multicentric experience","volume":"30","author":"You","year":"2008","journal-title":"Brain Development"},{"key":"10.1016\/j.seizure.2009.10.008_bib29","first-page":"439","article-title":"Phase III clinical study of the new antiepileptic drug AD-810 (zonisamide) in patients with childhood epilepsy","volume":"41","author":"Oguni","year":"1988","journal-title":"Japanese Journal of Pediatrics"},{"issue":"8","key":"10.1016\/j.seizure.2009.10.008_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1528-1167.2006.00607.x","article-title":"Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs","volume":"47","author":"Loscher","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2009.10.008_bib31","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1177\/088307380401900104","article-title":"Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients","volume":"19","author":"Glauser","year":"2004","journal-title":"Journal of Child Neurology"},{"issue":"1","key":"10.1016\/j.seizure.2009.10.008_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/seiz.1999.0368","article-title":"Psychotic episodes during zonisamide treatment","volume":"9","author":"Miyamoto","year":"2000","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.seizure.2009.10.008_bib33","first-page":"132","article-title":"Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?","volume":"5","author":"Kanner","year":"2009","journal-title":"Nature Clinical Practice Neurology"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109002131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131109002131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:38:29Z","timestamp":1761010709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131109002131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1059131109002131"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2009.10.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2009.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}